Tests for noninferiority trials with binomial endpoints: A guide to modern and quasi‐exact methods for biomedical researchers. (28th January 2019)

• Record Type: Journal Article
• Authors: Ripamonti, Enrico; Lloyd, Chris J.
• Is Part Of: Pharmaceutical statistics. Volume 18:Number 3(2019)
• Page Start: 377
• Page End: 387
• Publication Date: 2019-01-28
• Subjects: estimation -- exact test -- maximisation -- noninferiority -- nuisance parameters; Pharmacy -- Statistical methods -- Periodicals; Pharmacy -- Statistics -- Periodicals; 615.10727
• DOI: 10.1002/pst.1929
• Languages: English
• ISSNs: 1539-1604

Abstract

Abstract : Applied statisticians and pharmaceutical researchers are frequently involved in the design and analysis of clinical trials where at least one of the outcomes is binary. Treatments are judged by the probability of a positive binary response. A typical example is the noninferiority trial, where it is tested whether a new experimental treatment is practically not inferior to an active comparator with a prespecified margin δ . Except for the special case of δ = 0, no exact conditional test is available although approximate conditional methods (also called second‐order methods) can be applied. However, in some situations, the approximation can be poor and the logical argument for approximate conditioning is not compelling. The alternative is to consider an unconditional approach. Standard methods like the pooled z‐test are already unconditional although approximate. In this article, we review and illustrate unconditional methods with a heavy emphasis on modern methods that can deliver exact, or near exact, results. For noninferiority trials based on either rate difference or rate ratio, our recommendation is to use the so‐called E‐procedure, based on either the score or likelihood ratio statistic. This test is effectively exact, computationally efficient, and respects monotonicity constraints in practice. We support our assertions with a numerical study, and we illustrate the concepts developed in theory with a clinical example in pulmonary oncology; R code to conduct all these analyses is available from the authors.